Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Catheter Ablation | 10 | 2023 | 2758 | 1.470 |
Why?
|
Atrial Fibrillation | 11 | 2023 | 5033 | 1.170 |
Why?
|
Tachycardia, Ectopic Atrial | 1 | 2023 | 66 | 0.900 |
Why?
|
Tachycardia, Supraventricular | 2 | 2023 | 263 | 0.890 |
Why?
|
Sleep Apnea, Central | 1 | 2017 | 84 | 0.560 |
Why?
|
Continuous Positive Airway Pressure | 2 | 2022 | 546 | 0.510 |
Why?
|
Tachycardia, Ventricular | 1 | 2023 | 1272 | 0.500 |
Why?
|
Electric Countershock | 2 | 2019 | 534 | 0.490 |
Why?
|
Sleep Apnea Syndromes | 1 | 2022 | 944 | 0.480 |
Why?
|
Sleep Apnea, Obstructive | 2 | 2017 | 1813 | 0.440 |
Why?
|
Vascular System Injuries | 1 | 2013 | 250 | 0.340 |
Why?
|
Electrophysiologic Techniques, Cardiac | 2 | 2023 | 493 | 0.300 |
Why?
|
Pulmonary Veins | 1 | 2013 | 761 | 0.290 |
Why?
|
Heptanoic Acids | 1 | 2009 | 343 | 0.290 |
Why?
|
Pravastatin | 1 | 2009 | 395 | 0.290 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2013 | 531 | 0.290 |
Why?
|
Aortic Diseases | 1 | 2013 | 743 | 0.280 |
Why?
|
Primary Prevention | 1 | 2013 | 1167 | 0.260 |
Why?
|
Aorta | 1 | 2013 | 2062 | 0.250 |
Why?
|
Death, Sudden, Cardiac | 1 | 2013 | 1542 | 0.240 |
Why?
|
High-Frequency Jet Ventilation | 1 | 2023 | 23 | 0.230 |
Why?
|
Pyrroles | 1 | 2009 | 1147 | 0.210 |
Why?
|
Anti-Arrhythmia Agents | 3 | 2022 | 788 | 0.210 |
Why?
|
Bed Rest | 1 | 2022 | 84 | 0.210 |
Why?
|
Acute Coronary Syndrome | 3 | 2012 | 2337 | 0.210 |
Why?
|
Atrioventricular Block | 1 | 2022 | 120 | 0.180 |
Why?
|
Amiodarone | 1 | 2021 | 211 | 0.170 |
Why?
|
Hypotension | 1 | 2023 | 884 | 0.150 |
Why?
|
Pacemaker, Artificial | 1 | 2022 | 815 | 0.140 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 3255 | 0.120 |
Why?
|
Arrhythmias, Cardiac | 1 | 2023 | 2267 | 0.110 |
Why?
|
Thromboembolism | 1 | 2019 | 987 | 0.110 |
Why?
|
Feasibility Studies | 1 | 2022 | 5078 | 0.100 |
Why?
|
Hemorrhage | 2 | 2022 | 3458 | 0.100 |
Why?
|
Cardiac Resynchronization Therapy Devices | 1 | 2013 | 124 | 0.100 |
Why?
|
Hirudins | 1 | 2012 | 183 | 0.100 |
Why?
|
Treatment Outcome | 9 | 2022 | 63042 | 0.090 |
Why?
|
Postoperative Complications | 1 | 2013 | 15281 | 0.090 |
Why?
|
Cicatrix | 1 | 2016 | 763 | 0.090 |
Why?
|
Retrospective Studies | 6 | 2023 | 77410 | 0.090 |
Why?
|
Aortic Valve Stenosis | 1 | 2022 | 1955 | 0.090 |
Why?
|
Patient Discharge | 1 | 2022 | 3317 | 0.090 |
Why?
|
Angioplasty | 1 | 2012 | 364 | 0.080 |
Why?
|
Antithrombins | 1 | 2012 | 304 | 0.080 |
Why?
|
Radionuclide Imaging | 1 | 2013 | 2034 | 0.080 |
Why?
|
Gadolinium | 1 | 2013 | 950 | 0.080 |
Why?
|
Humans | 18 | 2023 | 743811 | 0.070 |
Why?
|
Heart Atria | 1 | 2013 | 1357 | 0.070 |
Why?
|
Analgesics, Opioid | 1 | 2022 | 3677 | 0.070 |
Why?
|
Angina, Unstable | 1 | 2010 | 926 | 0.070 |
Why?
|
Thiophenes | 1 | 2010 | 589 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3155 | 0.060 |
Why?
|
Coronary Stenosis | 1 | 2010 | 833 | 0.060 |
Why?
|
Middle Aged | 10 | 2022 | 213241 | 0.060 |
Why?
|
Risk Factors | 5 | 2022 | 72252 | 0.060 |
Why?
|
Defibrillators, Implantable | 1 | 2013 | 1439 | 0.060 |
Why?
|
Cost-Benefit Analysis | 2 | 2013 | 5388 | 0.060 |
Why?
|
Seasons | 1 | 2009 | 1493 | 0.050 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2010 | 1874 | 0.050 |
Why?
|
Male | 11 | 2022 | 349776 | 0.050 |
Why?
|
Cholesterol, HDL | 1 | 2009 | 1813 | 0.050 |
Why?
|
Image Enhancement | 1 | 2013 | 2915 | 0.050 |
Why?
|
Adult | 7 | 2022 | 213889 | 0.050 |
Why?
|
Sotalol | 1 | 2021 | 49 | 0.050 |
Why?
|
Flecainide | 1 | 2021 | 42 | 0.050 |
Why?
|
Female | 10 | 2022 | 380020 | 0.050 |
Why?
|
Age Factors | 2 | 2020 | 18355 | 0.050 |
Why?
|
Piperazines | 1 | 2010 | 2487 | 0.040 |
Why?
|
Myocardial Infarction | 2 | 2012 | 11708 | 0.040 |
Why?
|
Cholesterol, LDL | 1 | 2009 | 2354 | 0.040 |
Why?
|
Health Care Costs | 1 | 2013 | 3207 | 0.040 |
Why?
|
Aged | 6 | 2022 | 163178 | 0.040 |
Why?
|
Peptide Fragments | 1 | 2012 | 5096 | 0.040 |
Why?
|
Coronary Angiography | 1 | 2010 | 4576 | 0.040 |
Why?
|
Medication Therapy Management | 1 | 2019 | 127 | 0.040 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2022 | 844 | 0.040 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2010 | 3070 | 0.040 |
Why?
|
Prognosis | 1 | 2017 | 29052 | 0.040 |
Why?
|
Prospective Studies | 2 | 2017 | 53250 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2022 | 57744 | 0.030 |
Why?
|
Electrocardiography | 3 | 2012 | 6441 | 0.030 |
Why?
|
Needs Assessment | 1 | 2019 | 1146 | 0.030 |
Why?
|
Young Adult | 4 | 2022 | 56392 | 0.030 |
Why?
|
Intraoperative Care | 1 | 2016 | 767 | 0.030 |
Why?
|
Aortic Valve | 1 | 2022 | 1920 | 0.030 |
Why?
|
Heart Conduction System | 1 | 2016 | 1047 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2020 | 2050 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3953 | 0.020 |
Why?
|
Creatine Kinase, MB Form | 1 | 2010 | 214 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2022 | 3530 | 0.020 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2012 | 641 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2022 | 3020 | 0.020 |
Why?
|
Registries | 1 | 2023 | 8090 | 0.020 |
Why?
|
Vascular Patency | 1 | 2010 | 887 | 0.020 |
Why?
|
Adolescent | 3 | 2022 | 85729 | 0.020 |
Why?
|
Drug Resistance | 1 | 2012 | 1606 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2013 | 35409 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10380 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2023 | 5319 | 0.020 |
Why?
|
Heparin | 1 | 2012 | 1637 | 0.020 |
Why?
|
Time Factors | 2 | 2020 | 40038 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3503 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2012 | 6620 | 0.010 |
Why?
|
Up-Regulation | 1 | 2010 | 4221 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6539 | 0.010 |
Why?
|
Coronary Vessels | 1 | 2012 | 3106 | 0.010 |
Why?
|
Recurrence | 1 | 2012 | 8337 | 0.010 |
Why?
|
Survival Analysis | 1 | 2012 | 10251 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12243 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2010 | 12354 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2010 | 9944 | 0.010 |
Why?
|
United States | 1 | 2020 | 69859 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2012 | 39001 | 0.010 |
Why?
|
Risk Assessment | 1 | 2010 | 23327 | 0.010 |
Why?
|
Concepts
(114)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(31)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_